Tine J, Junien J L
Arzneimittelforschung. 1976;26(9):1677-80.
The effect of 3-phenyl-4-dibutylaminoethyl-5-inimino-1,2,4-oxadiazole (butalamine) was investigated in vivo and in vitro on oxydophosphorylation of mitochondria isolated from rat liver. In vitro with succinate and glutamate-malate as oxydable substrates, butalamine stimulates respiration at lower concentrations (100% at 3 X 10(-4) M for succinate and 40% at 4 X 10(-4) M for glutamate-malate) and inhibits it at higher ones (50% at 1 mM). Butalamine inhibits State 3 respiration and decreases ADP/O. Data on respiration blocked by rutamycine and on the effects of DNP, show that butalamine affects oxydophosphorylation in vitro, probably before DNP reactions are involved. In contrast to DNP, butalamine is an uncompetitive inhibitor when succinate is used as substrate in State 3. The potent lipophilic properties of butalamine should be responsible for these unspecific effects. In vivo, at a dosage of 50 mg/kg p.o. over 8 days, no alteration of State 3, State 4, ADP/O and respiratory control ratio (RC) was found.
研究了3-苯基-4-二丁基氨基乙基-5-亚氨基-1,2,4-恶二唑(布他拉明)在体内和体外对从大鼠肝脏分离的线粒体氧化磷酸化的影响。在体外,以琥珀酸和谷氨酸-苹果酸作为可氧化底物时,布他拉明在较低浓度下刺激呼吸(琥珀酸在3×10⁻⁴M时刺激100%,谷氨酸-苹果酸在4×10⁻⁴M时刺激40%),而在较高浓度下抑制呼吸(1mM时抑制50%)。布他拉明抑制状态3呼吸并降低ADP/O。关于被鱼藤酮阻断的呼吸数据以及DNP的作用表明,布他拉明在体外影响氧化磷酸化,可能在涉及DNP反应之前。与DNP相反,当琥珀酸用作状态3的底物时,布他拉明是一种非竞争性抑制剂。布他拉明强大的亲脂性可能是这些非特异性作用的原因。在体内,口服剂量为50mg/kg,持续8天,未发现状态3、状态4、ADP/O和呼吸控制率(RC)有改变。